Potential prognostic value in human breast cancer of cytosolic Nme1 protein detection using an original hen specific antibody

British Journal of Cancer

Volumn 73, Issue 5, 1996, Pages 630-635

  Toulas, C ^a   Mihura, J ^a   De Balincourt, C ^a   Marques, B ^a   Marek, E ^a   Soula, G ^a,b   Roche, H ^a   Favre, G ^a,b  

^a INSTITUT CLAUDIUS REGAUD   (France)

^b UNIVERSITÉ DE TOULOUSE   (France)

Author keywords

Human breast tumour; Metastasis suppressor gene nme1; Nme1 specific antibody; Western blotting analysis

Indexed keywords

ANTIBODY; CELL PROTEIN; ESTROGEN RECEPTOR;

ANTIBODY PRODUCTION; ANTIGEN ANTIBODY REACTION; ARTICLE; BREAST CANCER; CANCER SURVIVAL; CONTROLLED STUDY; CYTOSOL; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; TUMOR SUPPRESSOR GENE;

EID: 0030027661     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.109     Document Type: Article

References (42)

1. ADAMI HO, GRAFFMAN S, LINDGREN A AND SALLSTROEM J. (1985). Prognostic implication of estrogen receptor content in breast cancer. Breast Cancer Res. Treat., 5, 293-297.
2. ARAI T, WATANABE M, ONODERA M, YAMASHITA T, MASUNAGA T, ITOYAMA S, ITOH K AND SUGAWARA I. (1993). Reduced nm23-H1 messenger RNA expression in metastatic lymph node from patients with papillary carcinoma of the thyroid. Am. J. Pathol., 142, 1938-1944.
3. BARNES R, MASOOD S, BARKER E, ROSENGARD AM, COGGIN DL, CROWELL T, KING CR, PORTER-JORDAN K, WARGOTZ ES, LIOTTA LS AND STEEG PS. (1991). Low nm23 expression in infiltrating ductal breast carcinomas correlates with patient survival. Am. J. Pathol., 139, 245-250.
4. BEVILACQUA G, SOBEL ME, LIOTTA LA AND STEEG PS. (1989). Association of low nm23 RNA levels in human primary infiltrating ductal breast carcinomas with lymph node involvement and other histopathologic indicators of high metastatic potential. Cancer Res., 49, 5185-5190.
5. BOIX L, BRUIX J, CAMPO J, SOLE M, CASTELLS A, FUSTER J, RIVERA F, CARDESA A AND RODES J. (1994). Nm23-H1 expression and disease recurrence after surgical resection of small hepatocellular carcinoma. Gastroenterology, 107, 486-491.
6. BRADFORD MM. (1976). A rapid and sensitive method for the quantitation of microgram of protein utilizing the principle of protein dye binding. Anal. Biochem., 72, 248-254.
7. BROWN AM, JELSTCH JM, ROBERTS M AND CHAMBON P. (1984). Activation of pS2 gene transcription in primary response to estrogen in a human breast cancer cell line MCF7. Proc. Natl Acad. Sci. USA, 81, 6344-6348.
8. CONTESSO G, MOURIESSE H, FRIEDMAN S, GENIN J, SARRAZIN D AND ROUESSE J. (1987). The importance of histologic grade in long term prognosis of breast cancer. A study of 1010 patients uniformly treated at the Institut Gustave Roussy. J. Clin. Oncol., 5, 1378-1386.
9. CROPP C, LIDEREAU R, LEONE A, LISCIA D, CAPPA A, CAMPBELL G, BARKER E, LEDOUSSAL V, STEEG P AND CALLAHAN R. (1994). Nme1 protein expression and loss of heterozygosity mutations in primary human breast tumors. J. Natl Cancer Inst., 86, 1167-1169.
10. GASSMANN M, THOMMES P, WEISER T AND HUBSCHER U. (1990). Efficient production of chicken egg yolk antibodies against a conserved mammalian protein. FASEB J., 4, 2528-2532.
11. GILLES AM, PRESECAN E, VONICA A AND LASCU I. (1991). Nucleoside diphosphate kinase from human erythrocytes. Structural characterization of the two polypeptide chains responsible for heterogeneity of the hexameric enzyme. J. Biol. Chem., 266, 8784-8789.
12. HENESSY C, HENRY JA, MAY F, WESTLEY B, ANGUS B AND LENNARD T. (1991). Expression of the metastatic gene nm23 in human breast cancer: an association with good prognosis. J. Natl Cancer Inst., 83, 281-285.
13. HENRY JA, PIGGOTT NH, MALLICK UK, NICHOLSON S, FARNDON JR, WESTLEY BR AND MAY FEB. (1991). pNR-2/pS2 immunohistochemical staining in breast cancer: correlation with prognostic factors and endocrine response. Br. J. Cancer, 63, 615-622.
14. HIRAYAMA R, SAWAI S, TAKAGI Y, MISHIMA Y, KIMURA N, SHIMADA N, ESAKI Y, KURASHIMA C, UTSUYAMA M AND HIROKAWA K. (1991). Positive relationship between expression of anti-metastatic factor (nm23 gene product or nucleoside diphosphate kinase) and good prognosis in human breast cancer. J. Natl Cancer Inst., 83, 1249-1250.
15. HOWLETT A, PETERSEN O, STEEG P AND BISELL M. (1994). A novel function for the nm23-H1 gene: overexpression in human breast carcinoma cells leads to the formation of basement membrane and growth arrest. J. Natl Cancer Inst., 86, 1838-1844.
16. KIMURA N AND SHIMADA N. (1988). Membrane-associated nucleoside diphosphate kinase from rat liver. J. Biol. Chem., 263, 4647-4653.
17. LACOMBE M-L, SASTRE-GARAU X, LASCU I, VONICA A, WALLET V, THIERY JP AND VERON M. (1991). Overexpression of nucleoside diphosphate kinase (nm23) in solid tumors. Eur. J. Cancer, 27, 1302-1307.
18. LAEMMLI UK. (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 27, 680-685.
19. LEONE A, WESLEY MCBRIDGE O, WESTON A, WANG M, ANGLARD P, CROPP C, GOEPEL J, LIDEREAU R, CALLAHAN R, MARSTON LINEHAN W, REES RC, HARRIS CC, LIOTTA L AND STEEG P. (1991). Somatic allelic deletion of nm23 in human cancer. Cancer Res., 51, 2490-2493.
20. MACDONALD NJ, DE LA ROSA A, BENEDICT MA, FREIDJE JM, KRUTSCH H AND STEEG P. (1993). A serine phosphorylation of Nm23 and not its nucleoside diphosphate kinase activity, correlates with suppression of tumor metastasis potential. J. Biol. Chem., 268, 25780-25789.
21. MANDAI M, KONISHI I, KOSHIYAMA M, MORI T, ARAO S, TASHIRO H, OKAMURA H, NOMURA H, HIAI H AND FUKUMOTO M. (1994). Expression of metastasis related nm23H1 and nm23H2 genes in ovarian carcinomas: correlation with clinicopathology, EGFR, c-erbB2, and c-erbB3 genes and sex steroid receptor expression. Cancer Res., 54, 1825-1830.
22. MUSS HB, THOR AD, BERRY DA, KUTE T, LIU ED, KOERNER F, CIRRINCIONE CT, BUDMAN DR, WOOD WC, BARCOS M AND HENDERSON IC. (1994). c-erbB2 expression and response to adjuvant therapy in women with node-positive early breast cancer. N. Engl. J. Med., 330, 1260-1266.
23. MYEROFF LL AND MARKOWITZ SD. (1993). Increased nm23 H1 and nm23H2 messenger RNA expression and absence of mutations in colon carcinomas of low and high metastatic potential. J. Natl Cancer Inst., 85, 147-152.
24. NAKAYAMA T, OHTSURA A, NAKAO K, SHIMA M, NAKATA K, WATANABE K, ISHII N, KIMURA N AND NAGATAKI S. (1992). Expression in human hepatocellular carcinoma of nucleoside diphosphate kinase, a homologue of the nm23 gene product. J. Natl Cancer Inst., 84, 1349-1354.
25. NICKERSON JA AND WELLS WW. (1984). The microtubules-associated nucleoside diphosphate kinase. J. Biol. Chem., 259, 11297-11304.
26. POSTEL EH, BERBERICH SJ, FLINT SJ AND FERRONE CA. (1993). Human c-myc transcription factor Puf identified as nme2 nucleoside diphosphate kinase, a candidate suppressor of tumor metastasis. Science, 261, 428-429.
27. REINER A. (1990). Histopathologic characterization of human breast cancer in correlation with estrogen receptor status. Cancer 61, 1149-1154.
28. RILKE F, COLNAGHI MI, CASCINELLI N, ANDREOLA S, BALDINI MT, BUFALINO R, DELLA PORTA G, MENARD S, PIEROTTI MA AND TESTORS A. (1991). Prognosis significance of HER/Neu expression in breast cancer and its relationship to other prognosis factors. Int. J. Cancer, 49, 44-49.
29. ROYDS JA, STEPHENSON TJ, REES RC, SHORTHOUSE AJ AND SILCOCKS PB. (1993). Nm23 protein expression in ductal in situ and invasive breast carcinoma. J. Natl Cancer Inst., 85, 727-731.
30. SASTRE-GARAU X, LACOMBE ML, JOUVE M, VERON M AND MAGDALENAT H. (1992). Nucleoside diphosphate kinase/ NM23 expression in breast cancer: lack of correlation with lymph node metastasis. Int. J. Cancer, 50, 533-538.
31. SAWAN A, LASCU I, VERON M, ANDERSON JJ, WRIGHT C, HORNE C AND ANGUS B. (1994). NDP-K/nm23 expression in human breast cancer in relation to relapse survival, and other prognostic factors: an immunohistochemical study. J. Pathol., 172, 27-34.
32. SIMPSON JF, O'MALLEY F, DUPONT WD AND PAGE DL. (1994). Heterogeneous expression of nm23 gene product in noninvasive breast carcinoma. Cancer, 73, 2352-2358.
33. SLAMON D. (1991). Expression of the nm23 gene and breast cancer prognosis. J. Natl Cancer Inst., 83, 229-231.
34. SMITH PK, KROHN RI, HERMANSON GT, MALLIA AK, GARTNER FH, PROVENZANO MD, FUJIMOTO EK, GOEKE NM, OLSON BJ AND KLENK DC. (1985). Measurement of protein using bicinchoninic acid. Anal. Biochem., 150, 76-85.
35. STAHL J, LEONE A, ROSENGARD A, PORTER L, KING R AND STEEG P. (1991). Identification of a second human nm23 gene, nm23-H2. Cancer Res., 51, 445-449.
36. STEEG P, BEVILACQUA G, KOPPER L, THORGEIRSSON U, TALMADGE E, LIOTTA L AND SOBEL M. (1988). Evidence for a novel gene associated with low tumor metastatic potential. J. Natl Cancer Inst., 80, 200-204.
37. TANDON AK, CLARK GM, CHAMNESS GC, ULLRICH A AND MCGUIRE WL. (1989). HER-2/neu oncogene protein and prognosis in breast cancer. J. Clin. Oncol., 7, 1120-1128.
38. TOKUNAGA Y, URANO T, FURUKAWA K, KONDO H, KANEMATSU T AND SHIKU H. (1993). Reduced expression of nm23-H1 but not nm23-H2 is concordant with the frequency of lymph node metastasis of human breast cancer. Int. J. Cancer, 55, 66-71.
39. WRIGHT C, ANGUS B, NICHOLSON S, SAINSBURY JR, CAIRNS J, GULLICK WJ, KELLY P, HARRIS AL AND HORNE CH. (1989). Expression of c-erb2 oncoprotein: a prognosis indicator in human breast cancer. Cancer Res., 49, 2087-2090.
40. XERRI L, GROB JJ, BATTYANI Z, GOUVERNET J, HASSOUN J AND BONERANDI JJ. (1994). Nm23 expression in metastasis of malignant melanoma is a predictive prognosis parameter correlated with survival. Br. J. Cancer, 70, 1224-1228.
41. YAMAGUCHI A, URANO T, FUSHIDA S, FURUKAWA K, NISHIMURA G, YONEMURA Y, MIYAZAKI I, NAKAGAWARA G AND SHIKU H. (1993). Inverse association of nm23H1 expression by colorectal cancer with liver metastasis. Br. J. Cancer, 68, 1020-1024.
42. YAMAGUCHI A, URANO T, GOI T, TAKEUCHI K, NIIMOTO S, NAKAGAWARA G, FURUKAWA K AND SHIKU H. (1994). Expression of human nm23-H1 and nm23-H2 in hepatocellular carcinoma. Cancer, 73, 2280-2284.